Prospective of ⁶⁸Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation

Table 1

Positron-emitting, gamma-emitting, and therapeutic radionuclides, their physical characteristics, and production mode. Adapted from [4].

Radionuclide	Half-life	(keV)	Radiation	Production
Positron emitters
^18F	110 min	634	β^+ (97%)	Accelerator
^64Cu	12.8 h	656	β^+ (19%)	Accelerator
^68Ga	67.6 min	1899, 770	β^+ (89%)	Generator
^89Zr	78.4 h	900	β^+ (23%)	Accelerator
^124I	4.17 d	2100	β^+ (23%)	Accelerator
Gamma emitters
^67Ga	78.26 h	91, 93, 185, 296, 388	γ	Accelerator
Tc	6.0 h	141	γ	Generator
^111In	67.9 h	245, 172 (0.5–25)	, Auger electrons	Accelerator
^123I	13.3 h	159	γ	Accelerator
Therapeutic radionuclides
^177Lu	6.71 d	113, 208.4 (598)	γ (β^-)	Reactor